Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 0 | 128 | 81 | 114 | 101 |
| Gross Profit | N/A | 128 | 81 | 114 | 101 |
| Operating Expenses | 23,788 | 21,577 | 19,594 | 17,542 | 16,360 |
| Operating Income | -23,788 | -21,449 | -19,513 | -17,428 | -16,259 |
| Interest Expense | 976 | 721 | 425 | 515 | 486 |
| Other Income | 307 | 197 | 0 | 224 | 236 |
| Pre-tax Income | -24,457 | -21,973 | -19,938 | -17,719 | -16,509 |
| Net Income Continuous | -24,457 | -21,973 | -19,938 | -17,719 | -16,509 |
| Net Income | $-24,457 | $-21,973 | $-19,938 | $-17,719 | $-16,509 |
| EPS Basic Total Ops | -7.40 | -8.00 | -7.40 | -6.60 | -6.10 |
| EPS Basic Continuous Ops | -7.39 | -8.05 | -7.37 | -6.57 | -6.13 |
| EPS Diluted Total Ops | -7.40 | -8.00 | -7.40 | -6.60 | -6.10 |
| EPS Diluted Continuous Ops | -7.39 | -8.05 | -7.37 | -6.57 | -6.13 |
| EBITDA(a) | $-22,644 | $-20,442 | $-18,589 | $-16,526 | $-15,493 |